Six questions as FDA takes new shot at stem cell clinics
The FDA issued a historic statement today promising to more clearly define its regulatory policies on stem cell therapies and to take strong action on some stem cell clinics that it views as “bad actors”. I’ve never the FDA use such clear-cut language before. I give big kudos to new FDA Commissioner Scott Gottlieb. It already […]
Six questions as FDA takes new shot at stem cell clinics Read More »